ANI Pharmaceuticals Inc

NASDAQ:ANIP   4:00:00 PM EDT
69.69
+0.14 (+0.20%)
7:26:51 PM EDT: $70.00 +0.31 (+0.45%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.47B
Current PE78.22
Forward PE 15.59
2yr Forward PE 13.83
See more stats
Estimates Current Quarter
Revenue$125.35 Million
Adjusted EPS$0.98
See more estimates
10-Day MA$68.72
50-Day MA$61.28
200-Day MA$57.32
See more pivots

ANI Pharmaceuticals Inc Stock, NASDAQ:ANIP

210 Main Street West, Baudette, Minnesota 56623
United States of America
Phone: +1.218.634.3500
Number of Employees: 642

Description

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.